Clinical Trial Update: Effects of Selective Inhibition of Cholesterol Absorption With Ezetimibe on Intestinal Cholesterol Homeostasis in Dyslipidemic Men With Insulin-resistance - a Pilot Study [Phase 3]

View source ↗

Summary

Phase 3 pilot study evaluating the effects of ezetimibe on intestinal cholesterol homeostasis in dyslipidemic men with insulin resistance; the study was complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Metabolic Syndrome

Drugs mentioned

• EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: Laval University | Conditions: Metabolic Syndrome X | Phase 3 | Status: COMPLETED | Results posted: 2016-04-12